Volume | 66,226 |
|
|||||
News | - | ||||||
Day High | 1.18 | Low High |
|||||
Day Low | 1.02 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Passage Bio Inc | PASG | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.13 | 1.02 | 1.18 | 1.19 | 1.13 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
290 | 66,226 | $ 1.11 | $ 73,515 | - | 0.5751 - 1.79 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:00:03 | 413 | $ 1.19 | USD |
Passage Bio Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
65.05M | 55.60M | - | 0 | -102.06M | -1.84 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Passage Bio News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PASG Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.27 | 1.30 | 1.02 | 1.15 | 326,619 | -0.08 | -6.30% |
1 Month | 1.31 | 1.64 | 1.02 | 1.30 | 164,857 | -0.12 | -9.16% |
3 Months | 1.61 | 1.79 | 1.02 | 1.39 | 295,582 | -0.42 | -26.09% |
6 Months | 0.6451 | 1.79 | 0.60 | 1.07 | 472,241 | 0.5449 | 84.47% |
1 Year | 1.05 | 1.79 | 0.5751 | 0.9760648 | 358,794 | 0.14 | 13.33% |
3 Years | 14.215 | 16.14 | 0.5751 | 3.61 | 325,177 | -13.03 | -91.63% |
5 Years | 22.27 | 38.23 | 0.5751 | 8.02 | 312,992 | -21.08 | -94.66% |
Passage Bio Description
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. |